Quality of herbal medicines: Challenges and solutions

Complementary Therapies in Medicine

Volumn 20, Issue 1-2, 2012, Pages 100-106

  Zhang, Junhua ^a,b   Wider, Barbara ^b   Shang, Hongcai ^a   Li, Xuemei ^a   Ernst, Edzard ^b  

^a TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b UNIVERSITY OF EXETER   (United Kingdom)

Author keywords

Contamination; Herbal medicine; Quality control; Safety

Indexed keywords

AMINOPHENAZONE; ARSENIC; CADMIUM; CHINESE DRUG; CHLORDIAZEPOXIDE; CHLORPHENIRAMINE; CHLORPHENOTANE; CLOMETHIAZOLE; COPPER; DEXAMETHASONE; DIAZEPAM; DICLOFENAC; DIPHENHYDRAMINE; GLIBENCLAMIDE; HEAVY METAL; HERBACEOUS AGENT; HEXACHLOROCYCLOHEXANE; HYDROCHLOROTHIAZIDE; INDOMETACIN; LEAD; MERCURY; ORGANOCHLORINE PESTICIDE; PARACETAMOL; PESTICIDE RESIDUE; PHENACETIN; PHENYLBUTAZONE; PROMETHAZINE; QUINTOZENE; THALLIUM; UNINDEXED DRUG;

ANALYTIC METHOD; DRUG CONTAMINATION; DRUG MANUFACTURE; DRUG QUALITY; DRUG SAFETY; GOOD AGRICULTURAL AND COLLECTION PRACTICE; GOOD MANUFACTURING PRACTICE; HERBAL MEDICINE; MICROBIAL CONTAMINATION; QUALITY CONTROL; REVIEW; RISK REDUCTION;

DRUG CONTAMINATION; GUIDELINES AS TOPIC; HUMANS; PHYTOTHERAPY; PLANT PREPARATIONS; QUALITY OF HEALTH CARE; REFERENCE STANDARDS;

EID: 84856520727     PISSN: 09652299     EISSN: 18736963     Source Type: Journal    
DOI: 10.1016/j.ctim.2011.09.004     Document Type: Review

References (63)

1. WHO WHO guidelines on good agricultural and collection practices (GACP) for medicinal plants 2003.
2. Ernst E. Herbal medicines-they are popular, but are they also safe?. Eur J Clin Pharmacol 2006, 62:1-2.
3. Kosalec I., Cvek J., Tomić S. Contaminants of medicinal herbs and herbal products. Arh Hig Rada Toksikol 2009, 60:485-501.
4. WHO Research guidelines for evaluating the safety and efficacy of herbal medicines 1993.
5. Ernst E. Toxic heavy metals and undeclared drugs in Asian herbal medicines. Trends Pharmacol Sci 2002, 23:136-139.
6. Xue J., Liu D.J., Chen S.L., Liao Y.H., Zou Z.M. Overview on external contamination sources in traditional Chinese medicines. Mode Tradit Chin Med Mater Med 2008, 10:91-96.
7. Ernst E., Thompson Coon J. Heavy metals in traditional Chinese medicines: a systematic review. Clin Pharmacol Ther 2001, 70:497-504.
8. Ernst E. Heavy metals in traditional Indian remedies. Eur J Clin Pharmacol 2002, 57:891-896.
9. Ko R.J. Adulterants in Asian patent medicines. N Engl J Med 1998, 339:847.
10. Obi E., Akunyili D.N., Ekpo B., Orisakwe O.E. Heavy metal hazards of Nigerian herbal remedies. Sci Total Environ 2006, 369:35-41.
11. Kalny P., Fijalek Z., Daszczuk A., Ostapczuk P. Determination of selected microelements in polish herbs and their infusions. Sci Total Environ 2007, 381:99-104.
12. Caldas E.D., Machado L.L. Cadmium, mercury and lead in medicinal herbs in Brazil. Food Chem Toxicol 2004, 42:599-603.
13. Garcia-Rico L., Leyva-Perez J., Jara-Marini M.E. Content and daily intake of copper, zink, lead, cadmium and mercury from dietary supplements in Mexico. Food Chem Toxicol 2007, 45:1599-1605.
14. Yee S.K., Chu S.S., Xu Y.M., Choo P.L. Regulatory control of Chinese proprietary medicines in Singapore. Health Policy 2005, 71:133-149.
15. Koh H.L., Woo S.O. Chinese proprietary medicines in Singapore: regulatory control of toxic heavy metals and undeclared drugs. Drug Saf 2000, 23:351-362.
16. Tian J.G., Jin H.Y., Du Q.L., Lin R.C., Peng F. Monitoring the heavy metals and pesticide residues in traditional Chinese medicines. Chin Pharm Aff 2006, 20:755-758.
17. Melchart D., Wagner H., Hager S., Saller R., Ernest E. Quality assurance and evaluation of Chinese medicinal drugs in a hospital of traditional Chinese medicine in Germany: a five-year report. Altern Ther 2001, 7:S24.
18. Jin H.Y., Wang Y., Sun L., Ma S.C. Current situation and suggestions on control of extrinsic harmful residues in Chinese medicinal materials. Chin Pharm Aff 2009, 23:639-642.
19. Saper R.B., Kales S.N., Paquin J., Burns M.J., Eisenberg D.M., Davis R.B., et al. Products heavy metal content of ayurvedic herbal medicine. JAMA 2004, 292:2868-2873.
20. Ang H.H. Lead contamination in Eugenia dyeriana herbal preparations from different commercial sources in Malaysia. Food Chem Toxicol 2008, 46:1969-1975.
21. Ang H.H., Lee K.L. Contamination of mercury in tongkat Ali hitam herbal preparations. Food Chem Toxicol 2006, 44:1245-1250.
22. The Pharmacopoeia Commission of China Pharmacopoeia of the People's Republic of China 2005, Chemical Industry Press.
23. European Medicines Agency Guideline on specifications: test procedures and acceptance criteria for herbal substances, herbal preparations and herbal medicinal products/traditional herbal medicinal products. CPMP/QWP/2820/00 Rev 1 2006.
24. Rong W.G., Guo H., Yang H. Current research status in China on pesticide contamination of plant material used in making Chinese herbal medicines. Agrochemicals 2006, 45:302-308.
25. Xue J., Hao L., Peng F. Residues of 18 organochlorine pesticides in 30 traditional Chinese medicines. Chemosphere 2008, 71:1051-1055.
26. Gao T.B., Zhang S.M., Tian J.G. Residues determination of cypermethrin, fenvalerate and deltamethrin in Radix Notoginseng, Radix Paeoniae Alba and American ginseng. Chin J Pharm Anal 1999, 19:31-33.
27. Chen C., Xiao Y.P., Song Y.Q. Investigation and analysis of organochlorine pesticide residues in traditional Chinese medicinal. J Shaanxi Normal Univ 2006, 34:264-271.
28. Li L.L., Yuan W.J., Zhang S.L. Analysis of organochlorine pesticide residues in the imported American ginseng and Senna. Chin Tradit Herb Drug 2003, 34:610.
29. Xia P.H., Zhang M.S., Chen W.S., Wu Q. Pyrethroid pesticide residues in medicinal plants in Guizhou GAP bases. Lishizhen Med Mater Med Res 2008, 19:3010-3012.
30. Zhang M.S., Zhang Z.K., Xia P.H., Chen W.S., Wu Q. Investigation on the organochlorine pesticides redidues in Chinese herbal materials from Guizhou GAP bases. J Shenyang Pharm Univ 2009, 26:473-476.
31. Ma H.Y. Simply discussion on the residues of organochlorine pesticides in Chinese herbal materials. China Pharm 2005, 16:1667-1669.
32. Zhou X., Yan M.W., Wan J. The situation and problems of using sulfur fumigation to process Chinese herbal materials. Lishizhen Med Mater Med Res 2009, 20:3104.
33. MCA Safety of herbal medicinal products 2002.
34. Bugno A., Almodovar A.A.B., Pereira T.C., Pinto T.J.A., Sabino M. Occurrence of toxigenic fungi in herbal drugs. Braz J Microbiol 2006, 37:47-51.
35. Aziz N.H., Youssef Y.A., El-Fouly M.Z., Moussa L.A. Contamination of some common medicinal plant samples and spices by fungi and their mycotoxins. Bot Bull Acad Sin 1998, 39:279-285.
36. Thembo K.M., Katerere D.R., Stockenström S., Shephard G.S., Vismer H.F. Mycological and mycotoxin contamination of traditional herbal medicines. S Afr J Bot 2007, 73:316-317.
37. Ali N., Hashim N.H., Saad B., Safan K., Nakajima M., et al. Evaluation of a method to determine the natural occurrence of aflatoxins in commercial traditional herbal medicines from Malaysia and Indonesia. Food Chem Toxicol 2005, 43:1763-1772.
38. Roy A.K. Mycological problems of crude herbal drugs: overview and challenges. Ind Phytopathol 2003, 56:1-13.
39. Gu Y.P., Liu J., Zhou L.J. Determination of residual organic solvents in andrographolide microcapsules by GC. Chin J Pharm 2004, 11:685-686.
40. Miller G.M., Stripp R. A study of western pharmaceuticals contained within samples of Chinese herbal/patent medicines collected from New York City's Chinatown. Legal Med 2007, 9:258-264.
41. Ernst E. Adulteration of Chinese herbal medicines with synthetic drugs: a systematic review. J Intern Med 2002, 252:107-113.
42. Yang Y.J. Current counterfeit Chinese herbal material in the market. Strait Pharm J 2007, 19:60-61.
43. Chan T.Y., Chan J.C., Tomlinson B., Critchley J.A. Chinese herbal medicines revisited: a Hong Kong perspective. Lancet 1993, 342:1532-1534.
44. Vanhaelen M., Vanhaelen-Fastre R., But P., Vanherweghem J.L. Identification of aristolochic acid in Chinese herbs. Lancet 1994, 343:174.
45. Lord G.M., Tagore R., Cook T., Gower P., Pusey C.D. Nephropathy caused by Chinese herbs in the UK. Lancet 1999, 354:481-482.
46. WHO WHO monographs on selected medicinal plants 1999.
47. Choi D.W., Kim J.H., Cho S.Y., Kim D.H., Chang S.Y. Regulation and quality control of herbal drugs in Korea. Toxicology 2002, 181-182:581-586.
48. Rotblatt M., Ziment I. Evidence-based herbal medicine 2002, Hanley and Belfus.
49. Wang Z.G., Ren J. Current status and future direction of Chinese herbal medicine. Trends Pharmacol Sci 2002, 23:347-348.
50. Bent S., Ko R. Commonly used herbal medicines in the United States: a review. Am J Med 2004, 116:478-485.
51. Harkey M.R., Henderson G.L., Gershwin M.E., Stern J.S., Hackman R.M. Variability in commercial ginseng products: an analysis of 25 preparations. Am J Clin Nutr 2001, 73:1101-1106.
52. WHO Supplementary guidelines on good manufacturing practices for the manufacture of herbal medicines 2006.
53. Zhu L.Z. The problems and countermeasure in the establishment of GAP bases of Chinese herbal materials. China N Trad Chin Med 2009, March.
54. Chen S.L., Ma X.J., Chen H.Z. A survey of bases for GAP of Chinese medicinal materials all over the country. Res Pract Chin Med 2003, 17:3-5.
55. Yuan Y.X. The farmers say NO to GAP. China Med Guide 2004, 10:23-25.
56. Brown D.J. Phytotherapy: herbal medicine meets clinical science. NARD J 1996, 118:41-52.
57. Zhou J., Qi L., Li P. Quality control of Chinese herbal medicines with chromatographic fingerprints. Se Pu 2008, 26:153-159.
58. Kasper S., Gastpar M., Müller W.E., Volz H.P., Dienel A., et al. Efficacy of St. John's wort extract WS 5570 in acute treatment of mild depression: a reanalysis of data from controlled clinical trials. Eur Arch Psychiatry Clin Neurosci 2008, 258:59-63.
59. Ip S.P., Zhao M., Xian Y., Chen M., Zong Y., Tjong Y.W., et al. Quality assurance for Chinese herbal formulae: standardization of IBS-20, a 20-herb preparation. Chin Med 2010, 5:8.
60. Zhang B.L., Wang Y.Y. The fundamental study on critical scientific problem of prescriptions-research and development modern Chinese medicines via the combination of standardized constituents. Chin J Nat Med 2005, 3:258-261.
61. [accessed in December 2010]. http://www.zdxb.zju.edu.cn/.
62. Lu D.P., Wang Q. Current study of APL treatment in China. Int J Hematol 2002, 76:316-318.
63. Wang L., Zhou G.B., Liu P., Song J.H., Liang Y., Yan X.J. Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia. Proc Natl Acad Sci U S A 2008, 105:4826-4831.